YMRC
BIIB icon

Yorktown Management & Research Company’s Biogen BIIB Stock Holding History

Yorktown Management & Research Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-900
Closed -$241K – 244
2020
Q2 		$241K Hold
900
– – 0.22% 241
2020
Q1 		$285K Sell
900
-300
-25% -$91K 0.29% 125
2019
Q4 		$356K Hold
1,200
– – 0.19% 164
2019
Q3 		$279K Buy
+1,200
New +$279K 0.15% 190

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Yorktown Management & Research Company's BIIB Position: Q3 2020 in Review

Yorktown Management & Research Company sold out of Biogen (BIIB) in Q3 2020, closing a stake of 900 shares — an estimated $241K sold.

Yorktown Management & Research Company first reported a position in BIIB in Q3 2019 and held it in 4 quarters. The position peaked at $356K in Q4 2019. 1,052 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Yorktown Management & Research Company reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Yorktown Management & Research Company sold 900 Biogen shares in Q3 2020, an estimated $241K.
  • Yorktown Management & Research Company first reported a position in Biogen in Q3 2019 and held it in 4 quarters.
  • Yorktown Management & Research Company's Biogen position peaked at $356K in Q4 2019.
  • 1,052 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Yorktown Management & Research Company's 13F filing for Q3 2020, filed 6 Nov 2020.